Rockefeller Capital Management L.P. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2024$1,851,583
-10.2%
55,344
+14.7%
0.01%
-16.7%
Q1 2024$2,062,355
+60.9%
48,253
+45.5%
0.01%
+50.0%
Q4 2023$1,281,731
-21.9%
33,153
-23.8%
0.00%
-33.3%
Q3 2023$1,641,902
+17.2%
43,505
+41.5%
0.01%
+20.0%
Q2 2023$1,401,177
+114844.8%
30,754
+2.3%
0.01%0.0%
Q1 2023$1,219
-23.9%
30,074
-4.4%
0.01%
-37.5%
Q4 2022$1,602
-99.9%
31,446
-0.9%
0.01%
-11.1%
Q3 2022$1,708,000
-2.6%
31,740
+16.2%
0.01%0.0%
Q2 2022$1,754,000
-28.9%
27,315
-14.2%
0.01%
-25.0%
Q1 2022$2,466,000
-14.4%
31,818
-5.2%
0.01%
-7.7%
Q4 2021$2,881,000
+3.3%
33,572
-3.2%
0.01%
-13.3%
Q3 2021$2,789,000
-59.3%
34,688
-59.2%
0.02%
-61.5%
Q2 2021$6,848,000
+31.1%
85,075
+37.3%
0.04%
+11.4%
Q1 2021$5,225,000
-3.8%
61,968
-8.5%
0.04%
-14.6%
Q4 2020$5,433,000
+11.2%
67,721
+11.4%
0.04%
-10.9%
Q3 2020$4,887,000
-3.2%
60,779
+3.6%
0.05%
-13.2%
Q2 2020$5,050,000
+29.9%
58,647
+22.4%
0.05%
+3.9%
Q1 2020$3,889,000
+87.4%
47,901
+93.0%
0.05%
+96.2%
Q4 2019$2,075,000
+9.4%
24,817
+14.5%
0.03%0.0%
Q3 2019$1,896,000
+99.2%
21,675
+86.4%
0.03%
+100.0%
Q2 2019$952,000
-3.5%
11,628
-4.2%
0.01%
-7.1%
Q1 2019$987,000
+194.6%
12,143
+138.3%
0.01%
+133.3%
Q4 2018$335,000
-14.8%
5,0950.0%0.01%0.0%
Q3 2018$393,000
+4.5%
5,0950.0%0.01%0.0%
Q2 2018$376,000
+15.3%
5,095
+1.7%
0.01%
+20.0%
Q1 2018$326,0005,0120.01%
Other shareholders
BAXTER INTL INC shareholders Q2 2023
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders